Harnessing Microglia and Macrophages for the Treatment of Glioblastoma
Open Access
- 5 June 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 506
Abstract
Glioblastoma multiforme (GBM) is the most malignant form of brain tumors, with a dismal prognosis. During the course of the disease, microglia and macrophages both infiltrate the tumor microenvironment and contribute considerably in glioma development. Thus, tumor-associated microglia and macrophages have recently emerged as potentially key therapeutic targets. Here, we review the physiology of microglia and their responses in brain cancer. We further discuss current treatment options for GBM using radiotherapy, and novel advances in our knowledge of microglia physiology, with emphasis on the recently discovered pathway that controls the baseline motility of microglia processes. We argue that the latter pathway is an interesting therapeutic avenue to pursue for the treatment of glioblastoma.Keywords
Funding Information
- European Commission
- Staatssekretariat für Bildung, Forschung und Innovation
- Ligue Genevoise Contre le Cancer
This publication has 109 references indexed in Scilit:
- Application of Nanoparticles on Diagnosis and Therapy in GliomasBioMed Research International, 2013
- Interleukins in glioblastoma pathophysiology: implications for therapyBritish Journal of Pharmacology, 2013
- Origin and differentiation of microgliaFrontiers in Cellular Neuroscience, 2013
- Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapyNanotechnology, Science and Applications, 2010
- Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and deathCell Death & Disease, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Regulation of the fructose transporter GLUT5 in health and diseaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007